Glialign receives investment to develop novel cell therapy

The UCL Technology Fund (UCLTF) and UK Innovation & Science Seed Fund (UKI2S), with support from Innovate UK, have invested in cell therapy company Glialign — a spin out company from UCL. Read more

4 May 2018 10:38 News